Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon

Recaps

I Can Extract Side Effects
VolumesArcsSummaries

Vol. 6Three Purities’ New Frontiers

Three Purities brought new drugs, artificial organs, medical AI, and brain-computer interfaces through major trials and into wider use. The volume left the company expanding its research, while Du Biao joined Huang Qin’s organ-transplantation project and resolved to prove himself as a scholar.

  • Wei Kang advanced Oral Insulin and selected acute radiation sickness and ischemia-reperfusion injury for Xifuning’s Phase III trials, while patients recovered after treatment for radiation sickness caused by contaminated fish.
  • Investigators traced widespread Pacific contamination to Sakura Country’s nuclear wastewater discharge, and Nishimura Yasuo lunged at a suited man at an official residence with a tube that fired three times.
  • Xue Shen’s artificial blood vessels entered clinical trials and Sanqing expanded its medical AI, diagnostic booths, and in vitro diagnostics as Xiao Mei attracted widespread use.
  • Wei Kang reported $100.1 billion in revenue and funded a Gusu University branch campus in Kun City, where Huang Qin decided to pursue a doctorate.
  • Wang Dali completed the Artificial Heart and doctors implanted it in Zhao Hong, while Ding Mian and Director Wu advanced Artificial Bladders to clinical trials.
  • Chen Yiqing’s team implanted brain-computer interface equipment in Zhang Li and prepared her to control a Whac-A-Mole game.
  • Zhang Li learned to control a robotic arm and computer through her thoughts, and Zhu Jun became a successful esports player with EDG using the Brain-Computer Interface.
  • Ding Mian and Xue Shen advanced the artificial kidney through pig trials, while Huang Qin recruited Du Biao to the xenogeneic organ-transplantation project.
Chapters 504–604 Read from Ch. 504

Arc 21Xifuning and the Radiation Crisis

Three Purities advanced Oral Insulin and several other clinical drug projects while its new antioxidant drug, Xifuning, proved effective against radiation sickness. As nuclear contamination triggered an international crisis and public demand for the drug, Nishimura Yasuo attacked a suited man at an official residence.

  • Wei Kang advanced Oral Insulin from successful trials toward overseas testing as Three Purities developed diabetes-management tools and patients reported better control.
  • Xue Shen demonstrated a working artificial blood vessel, and tests showed that implanted grafts integrated with mouse tissue.
  • Dr. Tang and Dr. Lin oversaw trials that improved young patients with kidney disease and helped Xiao Jie recover from social anxiety, while Zheng Jiamin enrolled Tiantian in a Dravet Syndrome drug trial.
  • Wei Kang selected acute radiation sickness and ischemia-reperfusion injury for the antioxidant drug’s Phase III trials, and Li Qing and his colleagues entered a trial after elevated radiation readings.
  • Director Sun investigated fishermen with radiation sickness and traced their illness to radioactive dried fish, while investigators connected widespread Pacific contamination to Sakura Country’s nuclear wastewater discharge.
  • The fishermen recovered after treatment with Xifuning, and Three Purities announced that its antioxidant drug was in Phase III trials as public concern about radiation contamination spread.
  • Jim and Jamie joined protests over radiation fears, while Nishimura Yasuo approached a suited man at an official residence and lunged at him with a tube that fired three times.
Chapters 504–52825 summaries Read

Arc 22AI, Vessels, and Expansion

Sanqing advanced its artificial blood vessels, launched Xiao Mei’s medical AI, and expanded into diagnostic booths and in vitro diagnostics. Its record revenue and a new university campus in Kun City left the company poised to grow its medical and research programs.

  • Sakura Country agreed to shut down the Fukushima Nuclear Power Plant and upgrade its wastewater treatment system, while Wei Kang secured approval for overseas Xifuning trials and began planning an anti-aging study with Pangu Research Institute.
  • Xue Shen and Ding Mian began developing an artificial bladder, and Xue Shen’s artificial blood vessel received approval for clinical trials before Sanqing’s grafts were used in major aortic and dialysis-access surgeries.
  • Sanqing’s small-bore artificial blood vessels entered Phase III trials, drawing interest from hospitals and putting Terumo and Maquet under pressure as doctors adopted the grafts for dialysis patients.
  • Xiang Gaofei presented Sky Eye 1.0, and Wei Kang introduced Xiao Mei, whose public beta gained attention after she demonstrated diagnoses, health checks, and other services.
  • When Xiao Mei’s popularity strained Sanqing’s computing capacity, Wei Kang reduced free consultations and directed Lu Tingfeng to develop an All-Purpose Diagnostic Booth combining tests with AI diagnoses and remote consultations.
  • Wei Kang agreed to connect Sanqing’s medical AI to national medical data and launch hospital pilot programs, while experts issued an AI Regulatory White Paper.
  • Wei Kang announced that Sanqing had earned $100.1 billion in revenue, and reports linked the company’s growth to Kun City’s economic rise as employees discussed pay, career plans, and further education.
  • Wei Kang funded a Gusu University branch campus in Kun City, and the new Gusu University Sanqing Campus opened plans for employee graduate programs, prompting Huang Qin to decide to pursue a doctorate.
Chapters 529–55425 summaries Read

Arc 23Three Purities’ New Frontiers

Three Purities advanced its medical technologies from hospital robots and artificial organs to bladder reconstruction and brain-computer interfaces. The arc ended as Zhang Li began the first human brain-computer interface test.

  • Gusu University drew students and families after Three Purities chose its campus and concentrated biology and medicine research, funding, and career opportunities there.
  • Xiang Gaofei partnered with Zhengyuan to equip hospital guide robots with Xiao Mei, and hospitals expanded the service after patients and staff saw its benefits.
  • Wang Dali completed a lightweight Artificial Heart, tested it in animals, and helped doctors implant it in Zhao Hong, who recovered and returned to daily life.
  • Three Purities began Artificial Heart clinical trials while Bill and Mr. Merck planned to use artificial organs in a secret effort to prolong human life.
  • Ding Mian and Director Wu advanced Artificial Bladders to clinical trials, and Zhu Jun regained independent urination with nerve reconstruction and a mouth-controlled device.
  • Chen Yiqing recruited Zhu Jun and Jian Lianyun to a brain-computer interface project, where the team used a macaque to demonstrate robotic arms controlled by brain signals.
  • Jian Lianyun implanted vascular sensors in the macaque, and the team confirmed that both vascular and cortical signals could control robotic arms.
  • Chen Yiqing’s team selected Zhang Li for the first human test, implanted the equipment, and prepared her to control a Whac-A-Mole game.
Chapters 555–57925 summaries Read

Arc 24A New Lease on Life

Three Purities’ Brain-Computer Interface opened new opportunities for disabled gamers, while its artificial kidney and surgical robotics projects advanced through trials and new research partnerships. Du Biao joined Huang Qin’s organ-transplantation project and resolved to prove himself as a scholar.

  • Zhang Li learned to control a robotic arm and computer through her thoughts, and Zhu Jun used the Brain-Computer Interface to become a successful esports player with EDG.
  • Wei Kang announced the affordable artificial heart and licensed Three Purities’ wireless-charging technology to electronics manufacturers, while Huawei and other companies brought wireless-charging products to market.
  • Wei Kang appointed Wang Dali deputy director of a Robot Laboratory and introduced Miao Shou, a multifunctional surgical robot intended to challenge Da Vinci.
  • Ding Mian and Xue Shen developed an external artificial kidney whose pig trials succeeded, and the device helped Huahua, Huihui, and human clinical-trial patients including Xiao Zhou and Zhao Xia.
  • Ding Mian proposed developing gene-edited pigs for growing human-compatible organs, and Huang Qin agreed to collaborate with Ding Mian’s Stem Cell Laboratory.
  • Huang Qin recruited Du Biao to the xenogeneic organ-transplantation project, and they planned research using genetic screening, engineered organ niches, and human stem cells.
  • Du Biao helped recruit students, prepared experiments and award materials, and resolved to work hard after Dean Lu encouraged him to pursue the Distinguished Young Scholar Award.
Chapters 580–60425 summaries Read
Volume 6 of 7
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS